A Well-Oiled Machine: Antithrombotic Therapy in the Era of TAVR, WATCHMAN, HM 3

Speakers:
Sarah Adie, PharmD, BCCP
Clinical Pharmacist Cardiology and
Adjunct Clinical Assistant Professor
University of Michigan

A Knowledge-Based Activity
ACPE UAN #  0016-0000-21-029-L01-P
1.0 contact hour
1.0 AMA PRA Category 1 Credit(s)™ CME
1.0 contact hour CNE

Learning Objectives:

• Identify potential thrombotic and bleeding complications post-transcatheter aortic valve replacement (TAVR) and discuss emerging evidence for antithrombotic regimens post-TAVR
• Explain thrombosis risk associated with WATCHMAN implantation and describe antithrombotic regimens reported in the literature to reduce this risk
• Describe bleeding and thrombotic complications with the HeartMate 3 (HM3) left ventricular assist device (LVAD) and examine current literature on oral antithrombotic regimens for patients with a HM3 LVAD

Speaker Disclosures

All speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial relationships with ineligible companies to disclose.